Cabaletta Bio Inc expected to post a loss of 60  cents a share - Earnings Preview

Cabaletta Bio

11/03/2022 11:29

* Cabaletta Bio Inc  CABA.OQ   CABA.O  is expected to show
no
change in quarterly revenue when it reports  results on March 14
(estimated). 
    * ​Refinitiv's mean analyst estimate for Cabaletta Bio Inc
is for
a loss of 60 cents per share. For the same quarter last year,
the company reported a loss of 40 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cabaletta
Bio Inc
is $18.5​, above​ its last closing price of $1.72. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.48       -0.50      -0.45     Beat    10.4
 Jun. 30 2021  -0.47       -0.50      -0.45     Beat    10.5
 Mar. 31 2021  -0.45       -0.46      -0.41     Beat    10.9​
 Dec. 31 2020  -0.37       -0.36      -0.40     Missed  -10.3
 ​​Sep.        -0.45       -0.44      -0.36     Beat    18.2
 30 2020                                                
 Jun. 30 2020  -0.41       -0.39      -0.35     Beat    10.5​
 Mar. 31 2020  -0.23       -0.23      -0.33     Missed  -44.1
 Dec. 31 2019              -0.65      -0.33     Beat    49.2
 This summary was machine generated March 11 at 11:29 GMT.  All
figures in US dollars  unless otherwise stated